Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction

被引:4
|
作者
Lopes, Renato D. [1 ]
Pieper, Karen S. [1 ]
Stevens, Susanna R. [1 ]
Solomon, Scott D. [2 ]
McMurray, John J. V. [3 ]
Pfeffer, Marc A. [2 ]
Leimberger, Jeffrey D. [1 ]
Velazquez, Eric J. [1 ]
机构
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[3] Univ Glasgow, British Heart Fdn, Glasgow G12 8QQ, Lanark, Scotland
来源
关键词
heart failure; left ventricular systolic dysfunction; myocardial infarction; risk factor; ACUTE CORONARY SYNDROMES; INTERNATIONAL TRIAL; RISK SCORE; CARE UNIT; MORTALITY; PROGNOSIS; PROGNOSTICATION; VALSARTAN;
D O I
10.1161/JAHA.115.003045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Most studies of risk assessment or stratification in patients with myocardial infarction (MI) have been static and fail to account for the evolving nature of clinical events and care processes. We sought to identify predictors of mortality, cardiovascular death or nonfatal MI, and cardiovascular death or nonfatal heart failure (HF) over time in patients with HF, left ventricular systolic dysfunction, or both post-MI. Methods and Results-Using data from the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial, we developed models to estimate the association between patient characteristics and the likelihood of experiencing an event from the time of a follow-up visit until the next visit. The intervals are: hospital arrival to discharge or 14 days, whichever occurs first; hospital discharge to 30 days; 30 days to 6 months; and 6 months to 3 years. Models were also developed to predict the entire 3-year follow-up period using baseline information. Multivariable Cox proportional hazards modeling was used throughout with Wald chi-squares as the comparator of strength for each predictor. For the baseline model of overall mortality, the 3 strongest predictors were age (adjusted hazard ratio [HR], 1.35; 95% CI, 1.28-1.42; P<0.0001), baseline heart rate (adjusted HR, 1.17; 95% CI, 1.14-1.21; P<0.0001), and creatinine clearance (<= 100 mL/min; adjusted HR, 0.86; 95% CI, 0.84-0.89; P<0.0001). According to the integrated discrimination improvement (IDI) and net reclassification improvement (NRI) indices, the updated model had significant improvement over the model with baseline covariates only in all follow-up periods and with all outcomes. Conclusions-Patient information assessed closest to the time of the outcome was more valuable in predicting death when compared with information obtained at the time of the index hospitalization. Using updated patient information improves prognosis over using only the information available at the time of the index event.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Bilirubin is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction
    Valeur, N.
    Andersson, C.
    Schou, M.
    Gustafsson, F.
    Torp-Pedersen, C.
    Kober, L.
    EUROPEAN HEART JOURNAL, 2009, 30 : 874 - 874
  • [22] EplerenoneA Review of its Use in Left Ventricular Systolic Dysfunction and Heart Failure After Acute Myocardial Infarction
    Gillian M. Keating
    Greg L. Plosker
    Drugs, 2004, 64 : 2689 - 2707
  • [23] Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction
    Valeur, Nana
    Nielsen, Olav Wendelboe
    McMurray, John J. V.
    Torp-Pedersen, Christian
    Kober, Lars
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (06) : 577 - 584
  • [24] Eplerenone A review of its use in left ventricular systolic dysfunction and heart failure after acute myocardial infarction
    Keating, GM
    Plosker, GL
    DRUGS, 2004, 64 (23) : 2689 - 2707
  • [25] Beneficial neurohumoral profile in left ventricular systolic dysfunction following acute myocardial infarction
    Balciunaite, Giedre
    Rudys, Alfredas
    Bickauskait, Nelli
    Zakarkaite, Diana
    Skorniakov, Viktor
    Celutkiene, Jelena
    Laucevicius, Aleksandras
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (01): : 64 - 73
  • [26] Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both
    Shah, Amil M.
    Hung, Chung-Lieh
    Shin, Sung Hee
    Skali, Hicham
    Verma, Anil
    Ghali, Jalal K.
    Kober, Lars
    Velazquez, Eric J.
    Rouleau, Jean L.
    McMurray, John J. V.
    Pfeffer, Marc A.
    Solomon, Scott D.
    AMERICAN HEART JOURNAL, 2011, 162 (04) : 685 - 691
  • [27] Time course of morbidity and mortality after a myocardial infarction complicated by left ventricular systolic dysfunction or heart failure
    Cleland, JG
    Kjekshus, J
    Dickstein, K
    Orn, S
    Romo, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 536A - 537A
  • [28] Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction
    Weir R.A.P.
    McMurray J.J.V.
    Current Heart Failure Reports, 2006, 3 (4) : 175 - 180
  • [29] Detection of myocardial infarction in heart failure patients with severe left ventricular systolic dysfunction by contrast enhanced MRI
    Bello, D
    Karam, C
    Parker, M
    Farah, G
    Vargas, J
    Judd, RM
    Bonow, RO
    Gheorghiade, M
    Kim, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 186A - 186A
  • [30] Valsartan: A review of its use in patients with heart failure and/or left ventricular systolic dysfunction after myocardial infarction
    Croom K.F.
    Keating G.M.
    American Journal of Cardiovascular Drugs, 2004, 4 (6) : 395 - 404